nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—CYP1A2—Sorafenib—liver cancer	0.191	0.543	CbGbCtD
Griseofulvin—CYP3A4—Sorafenib—liver cancer	0.0998	0.284	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—liver cancer	0.0606	0.173	CbGbCtD
Griseofulvin—Nephrotic syndrome—Sorafenib—liver cancer	0.0352	0.107	CcSEcCtD
Griseofulvin—Proteinuria—Sorafenib—liver cancer	0.0194	0.0586	CcSEcCtD
Griseofulvin—Protein urine present—Sorafenib—liver cancer	0.0191	0.0578	CcSEcCtD
Griseofulvin—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.0175	0.0548	CbGpPWpGaD
Griseofulvin—Neuropathy—Sorafenib—liver cancer	0.016	0.0484	CcSEcCtD
Griseofulvin—CYP1A2—Arylamine metabolism—NAT2—liver cancer	0.0144	0.0453	CbGpPWpGaD
Griseofulvin—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.0105	0.033	CbGpPWpGaD
Griseofulvin—Oral candidiasis—Epirubicin—liver cancer	0.00989	0.03	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Sorafenib—liver cancer	0.00932	0.0282	CcSEcCtD
Griseofulvin—Oral candidiasis—Doxorubicin—liver cancer	0.00915	0.0277	CcSEcCtD
Griseofulvin—Erythema multiforme—Sorafenib—liver cancer	0.00807	0.0245	CcSEcCtD
Griseofulvin—Erythema—Sorafenib—liver cancer	0.00743	0.0225	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00691	0.0209	CcSEcCtD
Griseofulvin—Angioedema—Sorafenib—liver cancer	0.00679	0.0206	CcSEcCtD
Griseofulvin—Leukopenia—Sorafenib—liver cancer	0.00665	0.0202	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00639	0.0194	CcSEcCtD
Griseofulvin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00631	0.0198	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen metabolism—GSTA1—liver cancer	0.00607	0.019	CbGpPWpGaD
Griseofulvin—Candida infection—Epirubicin—liver cancer	0.006	0.0182	CcSEcCtD
Griseofulvin—Neuropathy—Epirubicin—liver cancer	0.0059	0.0179	CcSEcCtD
Griseofulvin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.0058	0.0182	CbGpPWpGaD
Griseofulvin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.0057	0.0179	CbGpPWpGaD
Griseofulvin—Candida infection—Doxorubicin—liver cancer	0.00555	0.0168	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—liver cancer	0.00546	0.0165	CcSEcCtD
Griseofulvin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00537	0.0168	CbGpPWpGaD
Griseofulvin—Dyspepsia—Sorafenib—liver cancer	0.00534	0.0162	CcSEcCtD
Griseofulvin—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.0053	0.0166	CbGpPWpGaD
Griseofulvin—Fatigue—Sorafenib—liver cancer	0.00523	0.0158	CcSEcCtD
Griseofulvin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.00489	0.0153	CbGpPWpGaD
Griseofulvin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00487	0.0153	CbGpPWpGaD
Griseofulvin—Urticaria—Sorafenib—liver cancer	0.00482	0.0146	CcSEcCtD
Griseofulvin—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00468	0.0147	CbGpPWpGaD
Griseofulvin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00456	0.0138	CcSEcCtD
Griseofulvin—Hypersensitivity—Sorafenib—liver cancer	0.00447	0.0135	CcSEcCtD
Griseofulvin—Asthenia—Sorafenib—liver cancer	0.00435	0.0132	CcSEcCtD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00431	0.0135	CbGpPWpGaD
Griseofulvin—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00429	0.0135	CbGpPWpGaD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00424	0.0133	CbGpPWpGaD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00422	0.0128	CcSEcCtD
Griseofulvin—Diarrhoea—Sorafenib—liver cancer	0.00415	0.0126	CcSEcCtD
Griseofulvin—Dizziness—Sorafenib—liver cancer	0.00401	0.0122	CcSEcCtD
Griseofulvin—Vomiting—Sorafenib—liver cancer	0.00386	0.0117	CcSEcCtD
Griseofulvin—Rash—Sorafenib—liver cancer	0.00382	0.0116	CcSEcCtD
Griseofulvin—Dermatitis—Sorafenib—liver cancer	0.00382	0.0116	CcSEcCtD
Griseofulvin—Headache—Sorafenib—liver cancer	0.0038	0.0115	CcSEcCtD
Griseofulvin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00377	0.0118	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—liver cancer	0.00364	0.0114	CbGpPWpGaD
Griseofulvin—Nausea—Sorafenib—liver cancer	0.0036	0.0109	CcSEcCtD
Griseofulvin—CYP1A2—Xenobiotics—CYP2E1—liver cancer	0.00359	0.0113	CbGpPWpGaD
Griseofulvin—CYP1A2—Tamoxifen metabolism—CYP2E1—liver cancer	0.00345	0.0108	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—UGDH—liver cancer	0.00345	0.0108	CbGpPWpGaD
Griseofulvin—Neuropathy peripheral—Epirubicin—liver cancer	0.00345	0.0104	CcSEcCtD
Griseofulvin—CYP1A2—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00344	0.0108	CbGpPWpGaD
Griseofulvin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00344	0.0108	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—PPARA—liver cancer	0.00333	0.0104	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00333	0.0104	CbGpPWpGaD
Griseofulvin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00331	0.0104	CbGpPWpGaD
Griseofulvin—Agranulocytosis—Epirubicin—liver cancer	0.00328	0.00994	CcSEcCtD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00327	0.0103	CbGpPWpGaD
Griseofulvin—Neuropathy peripheral—Doxorubicin—liver cancer	0.00319	0.00966	CcSEcCtD
Griseofulvin—Hepatitis—Epirubicin—liver cancer	0.00316	0.00956	CcSEcCtD
Griseofulvin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00309	0.00967	CbGpPWpGaD
Griseofulvin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00306	0.0096	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—liver cancer	0.00305	0.00955	CbGpPWpGaD
Griseofulvin—Agranulocytosis—Doxorubicin—liver cancer	0.00304	0.00919	CcSEcCtD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—ESR1—liver cancer	0.00302	0.00946	CbGpPWpGaD
Griseofulvin—Erythema multiforme—Epirubicin—liver cancer	0.00298	0.00904	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—GSTA2—liver cancer	0.00297	0.0093	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen metabolism—GSTM1—liver cancer	0.00296	0.00929	CbGpPWpGaD
Griseofulvin—Hepatitis—Doxorubicin—liver cancer	0.00292	0.00884	CcSEcCtD
Griseofulvin—CYP1A2—Estrogen metabolism—CYP1A1—liver cancer	0.00281	0.0088	CbGpPWpGaD
Griseofulvin—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00277	0.00869	CbGpPWpGaD
Griseofulvin—Erythema multiforme—Doxorubicin—liver cancer	0.00276	0.00836	CcSEcCtD
Griseofulvin—Erythema—Epirubicin—liver cancer	0.00275	0.00832	CcSEcCtD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00274	0.00859	CbGpPWpGaD
Griseofulvin—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00267	0.00836	CbGpPWpGaD
Griseofulvin—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00265	0.00831	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00259	0.00812	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.00259	0.00812	CbGpPWpGaD
Griseofulvin—CYP1A2—Xenobiotics—CYP1A1—liver cancer	0.00258	0.00809	CbGpPWpGaD
Griseofulvin—Erythema—Doxorubicin—liver cancer	0.00254	0.0077	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00252	0.00791	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.00252	0.00791	CbGpPWpGaD
Griseofulvin—CYP1A2—Tamoxifen metabolism—CYP1A1—liver cancer	0.00248	0.00778	CbGpPWpGaD
Griseofulvin—Leukopenia—Epirubicin—liver cancer	0.00246	0.00745	CcSEcCtD
Griseofulvin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00238	0.00747	CbGpPWpGaD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00235	0.00737	CbGpPWpGaD
Griseofulvin—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00229	0.00717	CbGpPWpGaD
Griseofulvin—Leukopenia—Doxorubicin—liver cancer	0.00228	0.00689	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00226	0.0071	CbGpPWpGaD
Griseofulvin—Confusional state—Epirubicin—liver cancer	0.00226	0.00685	CcSEcCtD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00222	0.00696	CbGpPWpGaD
Griseofulvin—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00217	0.00679	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00212	0.00664	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00211	0.00663	CbGpPWpGaD
Griseofulvin—Confusional state—Doxorubicin—liver cancer	0.00209	0.00634	CcSEcCtD
Griseofulvin—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00208	0.00651	CbGpPWpGaD
Griseofulvin—Insomnia—Epirubicin—liver cancer	0.00203	0.00614	CcSEcCtD
Griseofulvin—CYP1A2—Biological oxidations—UGDH—liver cancer	0.00202	0.00633	CbGpPWpGaD
Griseofulvin—Paraesthesia—Epirubicin—liver cancer	0.00201	0.0061	CcSEcCtD
Griseofulvin—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00199	0.00625	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA3—liver cancer	0.00198	0.00621	CbGpPWpGaD
Griseofulvin—Dyspepsia—Epirubicin—liver cancer	0.00197	0.00598	CcSEcCtD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—JUN—liver cancer	0.00195	0.00612	CbGpPWpGaD
Griseofulvin—Fatigue—Epirubicin—liver cancer	0.00193	0.00585	CcSEcCtD
Griseofulvin—CYP1A2—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00192	0.00601	CbGpPWpGaD
Griseofulvin—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00192	0.00601	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00191	0.006	CbGpPWpGaD
Griseofulvin—Insomnia—Doxorubicin—liver cancer	0.00188	0.00568	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—liver cancer	0.00186	0.00564	CcSEcCtD
Griseofulvin—Feeling abnormal—Epirubicin—liver cancer	0.00185	0.0056	CcSEcCtD
Griseofulvin—CYP1A2—Tryptophan metabolism—CYP2E1—liver cancer	0.00185	0.00578	CbGpPWpGaD
Griseofulvin—Dyspepsia—Doxorubicin—liver cancer	0.00183	0.00553	CcSEcCtD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00181	0.00569	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA4—liver cancer	0.00181	0.00568	CbGpPWpGaD
Griseofulvin—Fatigue—Doxorubicin—liver cancer	0.00179	0.00542	CcSEcCtD
Griseofulvin—Urticaria—Epirubicin—liver cancer	0.00178	0.00539	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA2—liver cancer	0.00177	0.00554	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00171	0.00537	CbGpPWpGaD
Griseofulvin—Feeling abnormal—Doxorubicin—liver cancer	0.00171	0.00518	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.0017	0.00534	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.00169	0.0053	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.00168	0.00528	CbGpPWpGaD
Griseofulvin—Hypersensitivity—Epirubicin—liver cancer	0.00165	0.005	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—liver cancer	0.00165	0.00499	CcSEcCtD
Griseofulvin—Asthenia—Epirubicin—liver cancer	0.00161	0.00487	CcSEcCtD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.00158	0.00497	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—UGDH—liver cancer	0.00156	0.00488	CbGpPWpGaD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00154	0.00484	CbGpPWpGaD
Griseofulvin—Diarrhoea—Epirubicin—liver cancer	0.00153	0.00465	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—liver cancer	0.00153	0.00463	CcSEcCtD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00149	0.00468	CbGpPWpGaD
Griseofulvin—Asthenia—Doxorubicin—liver cancer	0.00149	0.00451	CcSEcCtD
Griseofulvin—Dizziness—Epirubicin—liver cancer	0.00148	0.00449	CcSEcCtD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00147	0.00462	CbGpPWpGaD
Griseofulvin—Vomiting—Epirubicin—liver cancer	0.00143	0.00432	CcSEcCtD
Griseofulvin—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00142	0.00446	CbGpPWpGaD
Griseofulvin—Diarrhoea—Doxorubicin—liver cancer	0.00142	0.0043	CcSEcCtD
Griseofulvin—Rash—Epirubicin—liver cancer	0.00141	0.00428	CcSEcCtD
Griseofulvin—Dermatitis—Epirubicin—liver cancer	0.00141	0.00428	CcSEcCtD
Griseofulvin—Headache—Epirubicin—liver cancer	0.0014	0.00425	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—liver cancer	0.00137	0.00415	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.00135	0.00422	CbGpPWpGaD
Griseofulvin—Nausea—Epirubicin—liver cancer	0.00133	0.00403	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.00133	0.00416	CbGpPWpGaD
Griseofulvin—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.00133	0.00416	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00133	0.00416	CbGpPWpGaD
Griseofulvin—Vomiting—Doxorubicin—liver cancer	0.00132	0.00399	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—liver cancer	0.00131	0.00396	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—liver cancer	0.00131	0.00396	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—liver cancer	0.0013	0.00394	CcSEcCtD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00128	0.004	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00124	0.00389	CbGpPWpGaD
Griseofulvin—Nausea—Doxorubicin—liver cancer	0.00123	0.00373	CcSEcCtD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00121	0.00379	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00119	0.00374	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.00118	0.0037	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.00116	0.00363	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00115	0.00361	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.00114	0.00358	CbGpPWpGaD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00114	0.00356	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.0011	0.00344	CbGpPWpGaD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00107	0.00336	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.00106	0.00332	CbGpPWpGaD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00106	0.00332	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.00105	0.00328	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.00103	0.00324	CbGpPWpGaD
Griseofulvin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00102	0.00321	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.00101	0.00316	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000997	0.00313	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000986	0.00309	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000985	0.00309	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000972	0.00305	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000933	0.00293	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.00091	0.00285	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000906	0.00284	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000895	0.00281	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000882	0.00277	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000869	0.00272	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000832	0.00261	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000827	0.00259	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000827	0.00259	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000818	0.00257	CbGpPWpGaD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000816	0.00256	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000815	0.00255	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000807	0.00253	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000797	0.0025	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000788	0.00247	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000769	0.00241	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000761	0.00239	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00075	0.00235	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000747	0.00234	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000747	0.00234	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000731	0.00229	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000729	0.00228	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000711	0.00223	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000689	0.00216	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000671	0.0021	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000642	0.00201	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000638	0.002	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000634	0.00199	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000621	0.00195	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000608	0.00191	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GGT1—liver cancer	0.00059	0.00185	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000571	0.00179	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.00057	0.00179	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000532	0.00167	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000532	0.00167	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.00053	0.00166	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000528	0.00166	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000522	0.00164	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000496	0.00155	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000489	0.00153	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000487	0.00153	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.00048	0.00151	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00047	0.00147	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000462	0.00145	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000455	0.00143	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000455	0.00143	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000453	0.00142	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000449	0.00141	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000409	0.00128	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000403	0.00126	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000376	0.00118	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000371	0.00116	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000356	0.00112	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000351	0.0011	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000346	0.00109	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UGDH—liver cancer	0.000345	0.00108	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—EPT1—liver cancer	0.000325	0.00102	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TAT—liver cancer	0.000308	0.000965	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000303	0.000949	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UGDH—liver cancer	0.000266	0.000835	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—EPT1—liver cancer	0.00025	0.000785	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TAT—liver cancer	0.000237	0.000744	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000226	0.00071	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CPT1B—liver cancer	0.000209	0.000656	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GLUL—liver cancer	0.000209	0.000656	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NR1H4—liver cancer	0.000202	0.000632	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA3—liver cancer	0.000198	0.000622	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA4—liver cancer	0.000181	0.000568	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000177	0.000556	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA2—liver cancer	0.000177	0.000554	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA1—liver cancer	0.00017	0.000534	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAT2—liver cancer	0.000169	0.000529	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000162	0.000508	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ALDOB—liver cancer	0.000162	0.000507	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CPT1B—liver cancer	0.000161	0.000506	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GLUL—liver cancer	0.000161	0.000506	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NR1H4—liver cancer	0.000156	0.000488	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CRABP1—liver cancer	0.000154	0.000483	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA3—liver cancer	0.000153	0.00048	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA4—liver cancer	0.00014	0.000439	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000139	0.000435	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA2—liver cancer	0.000136	0.000428	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HPGDS—liver cancer	0.000135	0.000423	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000134	0.00042	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA1—liver cancer	0.000132	0.000413	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAT2—liver cancer	0.00013	0.000408	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ALDOB—liver cancer	0.000125	0.000391	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000122	0.000383	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00012	0.000378	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PSMD10—liver cancer	0.00012	0.000377	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PSMA4—liver cancer	0.00012	0.000377	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CRABP1—liver cancer	0.000119	0.000373	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GOT2—liver cancer	0.000117	0.000366	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2E1—liver cancer	0.00011	0.000344	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000106	0.000333	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HPGDS—liver cancer	0.000104	0.000326	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYCS—liver cancer	0.000103	0.000322	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GGT1—liver cancer	0.000101	0.000316	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GOT1—liver cancer	0.000101	0.000316	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PSMA4—liver cancer	9.27e-05	0.000291	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PSMD10—liver cancer	9.27e-05	0.000291	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTP1—liver cancer	9.06e-05	0.000284	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GOT2—liver cancer	9.02e-05	0.000283	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HMOX1—liver cancer	8.93e-05	0.00028	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2E1—liver cancer	8.48e-05	0.000266	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM1—liver cancer	8.33e-05	0.000261	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYCS—liver cancer	7.93e-05	0.000249	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP1A1—liver cancer	7.89e-05	0.000247	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GOT1—liver cancer	7.78e-05	0.000244	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GGT1—liver cancer	7.78e-05	0.000244	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MTHFR—liver cancer	7.36e-05	0.000231	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PPARA—liver cancer	7.22e-05	0.000226	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTP1—liver cancer	6.99e-05	0.000219	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HMOX1—liver cancer	6.9e-05	0.000216	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.48e-05	0.000203	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM1—liver cancer	6.43e-05	0.000201	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CG—liver cancer	6.18e-05	0.000194	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP1A1—liver cancer	6.09e-05	0.000191	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PPARG—liver cancer	5.97e-05	0.000187	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MTHFR—liver cancer	5.68e-05	0.000178	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PPARA—liver cancer	5.57e-05	0.000175	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CD—liver cancer	5.43e-05	0.00017	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ALB—liver cancer	5.36e-05	0.000168	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CG—liver cancer	4.77e-05	0.00015	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CB—liver cancer	4.74e-05	0.000149	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PPARG—liver cancer	4.6e-05	0.000144	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CD—liver cancer	4.19e-05	0.000131	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ALB—liver cancer	4.14e-05	0.00013	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CB—liver cancer	3.66e-05	0.000115	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CA—liver cancer	2.89e-05	9.05e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AKT1—liver cancer	2.36e-05	7.4e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CA—liver cancer	2.23e-05	6.99e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AKT1—liver cancer	1.82e-05	5.71e-05	CbGpPWpGaD
